RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+60.85%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$5.96B
AUM Growth
+$5.96B
(+44%)
Cap. Flow
+$508M
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
47.57%
Holding
116
New
26
Increased
35
Reduced
12
Closed
14
Top Buys
| 1 |
Arvinas
ARVN
|
$152M |
| 2 |
Globus Medical
GMED
|
$107M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$99M |
| 4 |
Pulmonx
LUNG
|
$74.8M |
| 5 |
Illumina
ILMN
|
$69.1M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$128M |
| 2 |
Baxter International
BAX
|
$86.6M |
| 3 |
Incyte
INCY
|
$30M |
| 4 |
Q32 Bio
QTTB
|
$26.9M |
| 5 |
VXRT
Vaxart
VXRT
|
$23.4M |
Sector Composition
| 1 | Healthcare | 94% |
| 2 | Financials | 0.18% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MiMedx Group
MDXG
$1.05B
| $24.5M | 0.41% |
2,700,320
| – | – |
|
52
Apyx Medical
APYX
$71.9M
| $24.4M | 0.41% |
3,391,279
| – | – |
|
53
Fulcrum Therapeutics
FULC
$353M
| $24.3M | 0.41% |
2,071,409
+920,844
| +80% | +$10.8M |
|
54
Johnson & Johnson
JNJ
$429B
| $23.6M | 0.4% |
149,761
| – | – |
|
55
Arbutus Biopharma
ABUS
$753M
| $21.2M | 0.36% |
5,978,355
| – | – |
|
56
ProQR Therapeutics
PRQR
$256M
| $21M | 0.35% |
5,009,768
+36,594
| +0.7% | +$154K |
|
57
TELA Bio
TELA
$65.4M
| $20.8M | 0.35% |
1,383,816
+5,040
| +0.4% | +$75.8K |
|
58
Penumbra
PEN
$10.5B
| $20.7M | 0.35% |
+118,273
| New | +$20.7M |
|
|
ODT
59
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $19.2M | 0.32% |
1,000,139
+883
| +0.1% | +$17K |
|
60
Exagen
XGN
$213M
| $16.5M | 0.28% |
1,250,131
| – | – |
|
|
BLU
61
DELISTED
BELLUS Health Inc.
BLU
| $15.8M | 0.26% |
5,189,862
+994,506
| +24% | +$3.02M |
|
62
Immunic
IMUX
$79.4M
| $14.1M | 0.24% |
920,814
+8,318
| +0.9% | +$127K |
|
|
AFIB
63
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $13M | 0.22% |
451,834
| – | – |
|
64
Regenxbio
RGNX
$498M
| $12.8M | 0.21% |
282,260
-36,174
| -11% | -$1.64M |
|
|
GNMK
65
DELISTED
GenMark Diagnostics, Inc
GNMK
| $11.1M | 0.19% |
762,994
| – | – |
|
66
Clearside Biomedical
CLSD
$26.7M
| $10.8M | 0.18% |
3,958,130
+10,612
| +0.3% | +$29.1K |
|
67
Aptevo Therapeutics
APVO
$5.56M
| $10.6M | 0.18% |
+288,236
| New | +$10.6M |
|
|
VINC
68
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $10.5M | 0.18% |
+500,000
| New | +$10.5M |
|
69
CytomX Therapeutics
CTMX
$350M
| $10M | 0.17% |
1,527,352
+1,349
| +0.1% | +$8.84K |
|
70
argenx
ARGX
$44.2B
| $9.34M | 0.16% |
31,752
| – | – |
|
|
LJPC
71
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $9.3M | 0.16% |
2,397,378
+2,349
| +0.1% | +$9.11K |
|
72
MoonLake Immunotherapeutics
MLTX
$3.78B
| $8.53M | 0.14% |
+750,000
| New | +$8.53M |
|
|
BWAY
73
Brainsway
BWAY
$296M
| $8.32M | 0.14% |
1,103,474
-3,946
| -0.4% | -$29.8K |
|
|
CERE
74
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $8.29M | 0.14% |
+500,000
| New | +$8.29M |
|
75
Scholar Rock
SRRK
$3.3B
| $8.07M | 0.14% |
+166,183
| New | +$8.07M |
|